Valuation: BioHarvest Sciences Inc.

Market Cap 46.02M 39.4M 36.67M 33.81M 63.52M 4.41B 64.59M 434M 170M 2.2B 173M 169M 7.27B P/E 2026 *
-3.85x
P/E 2027 * -6.06x
Enterprise Value 46.02M 39.4M 36.67M 33.81M 63.52M 4.41B 64.59M 434M 170M 2.2B 173M 169M 7.27B EV / Sales 2026 *
1.23x
EV / Sales 2027 * 0.93x
Free-Float
85.23%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 68 28/04/2026
Director of Finance/CFO - 27/10/2024
Chief Operating Officer 65 18/04/2023
Director TitleAgeSince
Chairman 68 26/09/2018
Director/Board Member 67 26/09/2018
Director/Board Member 84 06/02/2019
Change 5-day change 1-year change 3-year change Capi.($)
+6.06%-2.94% - - 47.83M
+0.51%-2.12%-12.47%-5.56% 13.1B
-0.46%-3.33%-33.92%-57.25% 4.92B
+0.49%-3.51%+2.66%+0.14% 4.87B
-1.73%-2.13%+2.36%-27.87% 4.16B
-0.59%-3.10%-26.69%+3.09% 3.55B
-0.97%-1.87%-10.62%+14.41% 3.41B
+3.46%-3.16%-6.72%-5.34% 3.28B
-1.46%-1.52%-16.34%-17.10% 2.47B
-5.02%+0.69%-5.64%-14.87% 1.72B
Average +0.03%-2.73%-11.93%-12.26% 4.61B
Weighted average by Cap. -0.15%-2.25%-12.30%-11.93%

Financials

2026 *2027 *
Net sales 37.42M 32.04M 29.82M 27.5M 51.65M 3.58B 52.52M 353M 138M 1.79B 140M 137M 5.91B 49.59M 42.46M 39.52M 36.44M 68.45M 4.75B 69.61M 468M 184M 2.37B 186M 182M 7.84B
Net income -12.02M -10.29M -9.58M -8.83M -16.59M -1.15B -16.87M -113M -44.48M -575M -45.13M -44.14M -1.9B -7.65M -6.55M -6.1M -5.62M -10.56M -732M -10.74M -72.11M -28.3M -366M -28.72M -28.09M -1.21B
Net Debt - -
Logo BioHarvest Sciences Inc.
BioHarvest Sciences Inc. is a Canada-based botanical synthesis company. The Company leverages its technology platform to grow plant-based compounds, without the need to grow the underlying plant. It is leveraging its botanical synthesis technology to develop science-based therapeutic solutions within two major business verticals; as a contract development and manufacturing organization (CDMO) on behalf of customers seeking plant-based compounds, and as a creator of nutraceutical health and wellness products, which include dietary supplements. It delivers phytochemicals such as age-defying antioxidants and polyphenols used for wellness. Its product pipeline is focused on polyphenols, which include grape cells, olive cells, and pomegranate cells. Its process involves selecting the specific plant cells that can create the targeted ingredients. It offers VINIA, which is a nutraceutical containing the entire matrix of polyphenols contained in red grapes, including Piceid resveratrol.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
2.030USD
Average target price
10.50USD
Spread / Average Target
+417.24%

Quarterly revenue - Rate of surprise